6-83191240-A-G
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting
The NM_015599.3(PGM3):c.-2-226T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000756 in 1,535,386 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_015599.3 intron
Scores
Clinical Significance
Conservation
Publications
- immunodeficiency 23Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_015599.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PGM3 | NM_015599.3 | MANE Select | c.-2-226T>C | intron | N/A | NP_056414.1 | |||
| PGM3 | NM_001199917.2 | c.29T>C | p.Ile10Thr | missense | Exon 2 of 14 | NP_001186846.1 | |||
| PGM3 | NM_001367287.1 | c.29T>C | p.Ile10Thr | missense | Exon 2 of 14 | NP_001354216.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PGM3 | ENST00000513973.6 | TSL:1 MANE Select | c.-2-226T>C | intron | N/A | ENSP00000424874.1 | |||
| PGM3 | ENST00000512866.5 | TSL:1 | c.-2-226T>C | intron | N/A | ENSP00000421565.1 | |||
| PGM3 | ENST00000283977.9 | TSL:5 | c.-40+1939T>C | intron | N/A | ENSP00000283977.5 |
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 152064Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000232 AC: 3AN: 129154 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000484 AC: 67AN: 1383204Hom.: 1 Cov.: 30 AF XY: 0.0000469 AC XY: 32AN XY: 682520 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000322 AC: 49AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.000323 AC XY: 24AN XY: 74400 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.29T>C (p.I10T) alteration is located in exon 2 (coding exon 1) of the PGM3 gene. This alteration results from a T to C substitution at nucleotide position 29, causing the isoleucine (I) at amino acid position 10 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Immunodeficiency 23 Uncertain:1
This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 10 of the PGM3 protein (p.Ile10Thr). This variant is present in population databases (rs373825865, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with PGM3-related conditions. ClinVar contains an entry for this variant (Variation ID: 541846). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at